26
Participants
Start Date
June 19, 2008
Primary Completion Date
February 28, 2011
Study Completion Date
July 10, 2013
Cardioblate surgical ablation system
This investigation is a prospective, non-randomized multicenter clinical trial evaluating the outcome of patients with AF requiring concomitant open heart surgery plus the Cardioblate Surgical Ablation System using the modified Maze III procedure. The trial population includes patients requiring valve replacements or repairs, atrial septal defect (ASD) repairs, patent foramen ovale (PFO) closure or coronary artery bypass grafts (CABG) procedures.
Surgical RF Ablation
This investigation is a prospective, nonrandomized multicenter clinical trial evaluating the outcome of patients with AF requiring concomitant open heart surgery plus the Cardioblate Surgical Ablation System using the modified Maze III procedure. The trial population includes patients requiring valve replacements or repairs, atrial septal defect (ASD) repairs, patent foramen ovale (PFO) closure or coronary artery bypass grafts (CABG) procedures.
Haukeland University Hospital - Department of Cardiothoracic Surgery, Bergen
St. Elizabeth Heart Center - Department of Cardiothoracic Surgery, Trondheim
Kerckhoff Clinic - Department of Thoracic & Cardiovascular Surgery, Bad Nauheim
Heart Center Cottbus - Department of Cardiac Surgery, Cottbus
Public Central Teaching Hospital - Department of Cardiac Surgery, Warsaw
Lead Sponsor
Medtronic Cardiovascular
INDUSTRY